A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis

URN to cite this document:: urn:nbn:de:bvb:355-epub-361514
DOI to cite this document:: 10.5283/epub.36151

Berenbaum, F. ; Grifka, Joachim ; Cazzaniga, S. ; D'Amato, M. ; Giacovelli, G. ; Chevalier, X. ; Rannou, F. ; Rovati, L. C. ; Maheu, E.

Preview

License: Allianz- bzw. Nationallizenz
PDF - Published Version
(343kB)

Date of publication of this fulltext: 05 Sep 2017 13:13

Alternative links to fulltext:DOI

Details

Preview

Export bibliographical data

Abstract

Objectives: To compare the effects of an intermediate molecular weight (MW) intra-articular hyaluronic acid (HA) with a low MW product on knee osteoarthritis (OA) symptoms. Methods: Patients with symptomatic knee OA were enrolled inarandomised, controlled, double-blind, parallel-group, non-inferiority trial with the possibility to shift to superiority. Patients were randomised to GO-ON(MW ...